272 related articles for article (PubMed ID: 19202057)
1. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation.
Courtney AH; Puffer EB; Pontrello JK; Yang ZQ; Kiessling LL
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2500-5. PubMed ID: 19202057
[TBL] [Abstract][Full Text] [Related]
2. Synthetic antigens reveal dynamics of BCR endocytosis during inhibitory signaling.
Courtney AH; Bennett NR; Zwick DB; Hudon J; Kiessling LL
ACS Chem Biol; 2014 Jan; 9(1):202-10. PubMed ID: 24131142
[TBL] [Abstract][Full Text] [Related]
3. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
[TBL] [Abstract][Full Text] [Related]
4. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.
Enterina JR; Jung J; Macauley MS
Biomed J; 2019 Aug; 42(4):218-232. PubMed ID: 31627864
[TBL] [Abstract][Full Text] [Related]
5. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
6. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
Tsubata T
Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
[TBL] [Abstract][Full Text] [Related]
7. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
8. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
9. N-Linked Glycosylation Regulates CD22 Organization and Function.
Wasim L; Buhari FHM; Yoganathan M; Sicard T; Ereño-Orbea J; Julien JP; Treanor B
Front Immunol; 2019; 10():699. PubMed ID: 31019513
[TBL] [Abstract][Full Text] [Related]
10. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
Haas KM; Johnson KL; Phipps JP; Do C
J Immunol; 2018 Mar; 200(5):1671-1681. PubMed ID: 29374074
[TBL] [Abstract][Full Text] [Related]
11. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
12. Discovery of multifold modified sialosides as human CD22/Siglec-2 ligands with nanomolar activity on B-cells.
Prescher H; Schweizer A; Kuhfeldt E; Nitschke L; Brossmer R
ACS Chem Biol; 2014 Jul; 9(7):1444-50. PubMed ID: 24807582
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
Ghosh S; Bandulet C; Nitschke L
Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
[TBL] [Abstract][Full Text] [Related]
14. Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells.
Meyer SJ; Böser A; Korn MA; Koller C; Bertocci B; Reimann L; Warscheid B; Nitschke L
J Immunol; 2020 Jun; 204(12):3360-3374. PubMed ID: 32341059
[TBL] [Abstract][Full Text] [Related]
15. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking.
Han S; Collins BE; Bengtson P; Paulson JC
Nat Chem Biol; 2005 Jul; 1(2):93-7. PubMed ID: 16408005
[TBL] [Abstract][Full Text] [Related]
16. CD22: an inhibitory enigma.
Walker JA; Smith KG
Immunology; 2008 Mar; 123(3):314-25. PubMed ID: 18067554
[TBL] [Abstract][Full Text] [Related]
17. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
[TBL] [Abstract][Full Text] [Related]
18. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling.
Danzer CP; Collins BE; Blixt O; Paulson JC; Nitschke L
Int Immunol; 2003 Oct; 15(10):1137-47. PubMed ID: 13679384
[TBL] [Abstract][Full Text] [Related]
19. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
Müller J; Nitschke L
Nat Rev Rheumatol; 2014 Jul; 10(7):422-8. PubMed ID: 24763061
[TBL] [Abstract][Full Text] [Related]
20. The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells.
Powell LD; Varki A
J Biol Chem; 1994 Apr; 269(14):10628-36. PubMed ID: 8144652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
